Literature DB >> 7296169

Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis.

S N Young.   

Abstract

1 Two mechanisms have been proposed to explain the decline in brain tryptophan and 5-hydroxytryptamine (5-HT) after administration of hydrocortisone and the subsequent induction of liver pyrrolase. These are depletion of tryptophan by high rates of tryptophan catabolism and inhibition of tryptophan uptake by elevated levels of the tryptophan catabolite, kynurenine.2 The increase in plasma kynurenine after hydrocortisone injection (25 mg/kg) was small, and kynurenine, at a concentration ten fold greater, did not inhibit tryptophan uptake by brain as measured by the Oldendorf technique. Thus, inhibition of tryptophan uptake by kynurenine is not an important mechanism in the control of brain tryptophan and 5-HT.3 The decline in brain tryptophan after hydrocortisone was comparable to that seen in other tissues, which comprise more than half of the body weight of a rat.4 The total decline in free tryptophan stores in whole animals treated with hydrocortisone was estimated to be about 450 mug. This amount of tryptophan would be catabolized by tryptophan pyrrolase in about 20 min, when the enzyme is induced, according to an earlier estimate of the rate of tryptophan catabolism in vivo.5 Tryptophan pyrrolase activity remains high for much longer than 20 min, suggesting that there is net protein catabolism, which releases tryptophan and prevents non-protein tryptophan levels falling very far.6 These results demonstrate that the decline in brain tryptophan and 5-HT after hydrocortisone is caused by depletion of tryptophan stores due to the high activity of tryptophan pyrrolase. However, our data suggest that this effect is diminished by release of tryptophan from proteins. Thus, peripheral protein metabolism may be an important factor in the control of brain tryptophan levels and 5-HT synthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7296169      PMCID: PMC2071760          DOI: 10.1111/j.1476-5381.1981.tb10480.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Influence of hydrocoritsone and glucagon on liver tyrosine transaminase and on brain tyrosine, norepinephrine and serotonin.

Authors:  O Benkert; N Matussek
Journal:  Nature       Date:  1970-10-03       Impact factor: 49.962

2.  The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.

Authors:  A R Green; G Curzon
Journal:  Biochem Pharmacol       Date:  1970-06       Impact factor: 5.858

3.  Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.

Authors:  W H Oldendorf
Journal:  Am J Physiol       Date:  1971-12

4.  Rat liver tryptophan pyrrolase activity and brain 5-hydroxytryptamine.

Authors:  G Curzon; A R Green
Journal:  Biochem J       Date:  1969-02       Impact factor: 3.857

5.  Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol.

Authors:  A R Green; G Curzon
Journal:  Nature       Date:  1968-12-14       Impact factor: 49.962

6.  Alpha-methyltryptophan and its actions on tryptophan metabolism.

Authors:  T L Sourkes
Journal:  Fed Proc       Date:  1971 May-Jun

7.  Relationship between alternate routes of tryptophan metabolism following administration of tryptophan peroxidase inducers or stressors.

Authors:  A Yuwiler; L Wetterberg; E Geller
Journal:  J Neurochem       Date:  1971-04       Impact factor: 5.372

8.  The determination of tryptophan in plasma, liver, and urine.

Authors:  W D Denckla; H K Dewey
Journal:  J Lab Clin Med       Date:  1967-01

Review 9.  L-kynurenine: its synthesis and possible regulatory function in brain.

Authors:  E M Gál; A D Sherman
Journal:  Neurochem Res       Date:  1980-03       Impact factor: 3.996

10.  Acid metabolites of monoamines in avian brain; effects of probenecid and reserpine.

Authors:  L Ahtee; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

View more
  23 in total

1.  Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.

Authors:  Yoshitaka Fujii
Journal:  Surg Endosc       Date:  2010-10-07       Impact factor: 4.584

Review 2.  RETRACTED ARTICLE: Combination Antiemetic Regimens for Prevention of Postoperative Nausea and Vomiting : Focus on High-Risk Patients.

Authors:  Yoshitaka Fujii
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

Review 3.  Management of postoperative nausea and vomiting in women scheduled for breast cancer surgery.

Authors:  Yoshitaka Fujii
Journal:  J Anesth       Date:  2011-10-01       Impact factor: 2.078

4.  The effect of transdermal scopolamine plus intravenous dexamethasone for the prevention of postoperative nausea and vomiting in patients with epidural PCA after major orthopedic surgery.

Authors:  Hyun Kyu Lee; Jae Ho Lee; Sung Sik Chon; Eun Kyoung Ahn; Jin Ho Kim; Yeon-Hee Jang
Journal:  Korean J Anesthesiol       Date:  2010-01-31

5.  Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.

Authors:  Yoshiji Ohta; Hisako Kubo; Koji Yashiro; Koji Ohashi; Yuji Tsuzuki; Naoya Wada; Yasuko Yamamoto; Kuniaki Saito
Journal:  J Physiol Sci       Date:  2016-06-30       Impact factor: 2.781

6.  Effects of the haem precursor 5-aminolaevulinate on tryptophan metabolism and disposition in the rat.

Authors:  A A Badawy; C J Morgan; N R Davis
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

7.  Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.

Authors:  Carlos R Dostal; Nicolaus S Gamsby; Marcus A Lawson; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2017-12-11       Impact factor: 7.217

Review 8.  Management of postoperative nausea and vomiting in children.

Authors:  Pasquale De Negri; Giorgio Ivani
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by acute administration of small doses of antidepressants.

Authors:  A A Badawy; M Evans
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

10.  Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.

Authors:  Alex D Klausing; Tsutomu Fukuwatari; David J Bucci; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2020-03-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.